Journal of Cancer Research and Therapeutics Close
 

Figure 7: Liver IHC-Bcl-2: (a) Control untreated rats: moderate hepatocellular cytoplasmic and membranous staining. (b) BME-treated rats: weak cytoplasmic and membranous staining of hepatocytes. (c) Cisplatin-treated rats: no positive staining. (d) Cisplatin and BME co-treated rats: moderate cytoplasmic staining in occasional hepatocytes (×400)

Figure 7: Liver IHC-Bcl-2: (a) Control untreated rats: moderate hepatocellular cytoplasmic and membranous staining. (b) BME-treated rats: weak cytoplasmic and membranous staining of hepatocytes. (c) Cisplatin-treated rats: no positive staining. (d) Cisplatin and BME co-treated rats: moderate cytoplasmic staining in occasional hepatocytes (×400)